Company intelligence / Profile preview

Endostart

Ownership: Private
Development stage: Commercial

Overview

Endostart has developed a proprietary magnetic balloon system—Endorail—that anchors and guides endoscopes through the GI tract to resolve looping issues. Clinical trials have demonstrated high safety and efficacy in completing difficult colonoscopies. The device received CE marking initially for colonoscopies, with expanded approval to small bowel/enteroscopic use in October 2024. It obtained FDA clearance for GI endoscopic use including colonoscopies in March 2024. Results from a multicenter clinical trial were presented at Digestive Disease Week Congress May 2024.

Therapeutic areas: Gastroenterology
Modalities: Device (Magnetic Balloon Anchoring Technology)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Endorail

Commercial

Indications: Gastrointestinal endoscopy

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Endostart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endostart.

Explore the full profile